TickerFactsScreenerDevelopers

Clearside Biomedical, Inc. (CLSDQ) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$22.71M2017: -$51.08M2018: -$79.20M2019: -$27.07M2020: -$13.12M2021: -$10.73M2022: -$13.37M2023: -$18.14M2024: -$24.70M-$24.70M
2016Operating Cash Flow (USD)2024
Fiscal YearOperating Cash FlowChange YoY
2024-$24.70M-36.2%
2023-$18.14M-35.7%
2022-$13.37M-24.5%
2021-$10.73M+18.2%
2020-$13.12M+51.5%
2019-$27.07M+65.8%
2018-$79.20M-55.0%
2017-$51.08M-124.9%
2016-$22.71M—